Seven Eight Capital, LP Takeda Pharmaceutical CO LTD Transaction History

Seven Eight Capital, LP

  • $918 Million
  • Q2 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$12.42 - $15.62 $143,823 - $180,879
11,580 New
11,580 $180,000
Q2 2022

Aug 04, 2022
BUY
$13.12 - $15.03 $12,096 - $13,857
922 Added 6.66%
14,772 $207,000
Q1 2022

May 11, 2022
SELL
$13.54 - $15.35 $110,608 - $125,394
-8,169 Reduced 37.1%
13,850 $198,000
Q4 2021

Feb 14, 2022
SELL
$13.17 - $16.4 $1.39 Million - $1.74 Million
-105,856 Reduced 82.78%
22,019 $300,000
Q3 2021

Nov 15, 2021
BUY
$16.3 - $17.26 $753,060 - $797,412
46,200 Added 56.57%
127,875 $2.1 Million
Q2 2021

Aug 13, 2021
BUY
$16.55 - $18.64 $1.35 Million - $1.52 Million
81,675 New
81,675 $1.38 Million
Q3 2020

Nov 16, 2020
SELL
$17.1 - $19.19 $304,722 - $341,965
-17,820 Closed
0 $0
Q2 2020

Aug 06, 2020
SELL
$14.59 - $19.5 $43,478 - $58,110
-2,980 Reduced 14.33%
17,820 $320,000
Q1 2020

May 14, 2020
BUY
$13.02 - $20.31 $92,780 - $144,729
7,126 Added 52.11%
20,800 $316,000
Q4 2019

Feb 13, 2020
SELL
$16.88 - $20.83 $455,760 - $562,410
-27,000 Reduced 66.38%
13,674 $270,000
Q3 2019

Nov 14, 2019
BUY
$16.15 - $17.99 $494,189 - $550,494
30,600 Added 303.75%
40,674 $700,000
Q2 2019

Aug 12, 2019
BUY
$16.58 - $20.49 $167,026 - $206,416
10,074 New
10,074 $178,000

Others Institutions Holding TAK

# of Institutions
320
Shares Held
70.4M
Call Options Held
939K
Put Options Held
233K
View Full List

About TAKEDA PHARMACEUTICAL CO LTD

TAK Quotes by TradingView
  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email